Inhibrx Biosciences (INBX) Interest & Investment Income (2023 - 2025)

Inhibrx Biosciences (INBX) has 3 years of Interest & Investment Income data on file, last reported at $1.3 million in Q4 2025.

• Interest & Investment Income for Q4 2025 came in at $1.3 million, down 34.45% year-over-year; the trailing twelve-month figure through Dec 2025 was $7.5 million (down 31.0% YoY), and the FY2025 annual result was $7.5 million, down 31.0% from the prior year.
• Interest & Investment Income declined to $1.3 million in Q4 2025 per INBX's latest filing, from $1.8 million in the prior quarter.
• Over five years, Interest & Investment Income peaked at $4.7 million in Q4 2023 and troughed at $1.3 million in Q4 2025.
• A 3-year average of $2.5 million and a median of $2.3 million in 2025 frame the typical range for Interest & Investment Income.
• On a YoY basis, Interest & Investment Income climbed as much as 24.44% in 2024 and fell as far as 57.35% in 2024.
• A 3-year view of Interest & Investment Income shows it stood at $4.7 million in 2023, then sank by 57.35% to $2.0 million in 2024, then slumped by 34.45% to $1.3 million in 2025.
• Business Quant data shows INBX's Interest & Investment Income at $1.3 million in Q4 2025, $1.8 million in Q3 2025, and $2.1 million in Q2 2025.